🇺🇸 FDA
Pipeline program

Zeposia 0.92 mg hard capsules

Approved small_molecule active

Quick answer

Zeposia 0.92 mg hard capsules for Relapsing Multiple Sclerosis (relapsing-remitting, relapsing-progressive) is a Approved program (small_molecule) at Verona Pharma Ireland Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Verona Pharma Ireland Limited
Indication
Relapsing Multiple Sclerosis (relapsing-remitting, relapsing-progressive)
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials